Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 aPriori aPriori +195.44%
#4 Bedrock Bedrock +78.59%
#5 Cysic Cysic +52.73%
#6 Prom Prom +41.94%
#7 Playnance Playnance +35.03%
#8 Bitway Bitway +27.63%
#9 Nillion Nillion +23.82%
#10 COTI COTI +23.81%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Neurobiological Technologies, Inc. Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc.

NTII
Clasificación en acciones #42270
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation... Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$2.70K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Neurobiological Technologies, Inc. (NTII)

Categoría

Healthcare
Ratio P/S de Neurobiological Technologies, Inc. (NTII)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Neurobiological Technologies, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Neurobiological Technologies, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR